UCB Logo

UCB

UCB | BR

Overview

Corporate Details

ISIN(s):
BE0002730118 (+5 more)
LEI:
2138008J191VLSGY5A09
Country:
Belgium
Address:
ALLÉE DE LA RECHERCHE 60, 1070 ANDERLECHT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions. And thanks to our focused, innovative and trusted solutions, our business is strong. Our people have lived our purpose each day since 1928, making critical investments in biopharmaceutical research and leading innovations that strive to achieve a meaningful impact on the lives of those we serve. UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 20:00
Major Shareholding Notification
EN PR.pdf
English 307.0 KB
2025-08-12 20:00
Major Shareholding Notification
FR PR.pdf
French 294.4 KB
2025-08-12 20:00
Major Shareholding Notification
NL PR.pdf
Dutch 289.3 KB
2025-07-31 07:00
Interim Report
UCB PR HY 2025 ENG.pdf
English 615.4 KB
2025-07-31 07:00
Earnings Release
UCB PR HY 2025 FR.pdf
French 590.2 KB
2025-07-31 07:00
Interim Report
UCB PR HY 2025 NL.pdf
Dutch 983.3 KB
2025-07-31 07:00
Interim Report
UCB_Half-Year_2025_Report-EN-FINAL.pdf
English 1.5 MB
2025-07-31 07:00
Interim Report
UCB_Half-Year_2025_Report-FR-FINAL.pdf
French 1.5 MB
2025-07-31 07:00
Interim Report
UCB_Half-Year_2025_Report-NL-FINAL.pdf
Dutch 1.5 MB
2025-07-10 20:00
Major Shareholding Notification
EN FMR 10.07.2025.pdf
English 348.5 KB
2025-07-10 20:00
Major Shareholding Notification
FR FMR 10.07.2025.pdf
French 304.0 KB
2025-07-10 20:00
Major Shareholding Notification
NL FMR 10.07.2025.pdf
Dutch 304.0 KB
2025-07-08 20:00
Major Shareholding Notification
EN Transparency BR.pdf
English 292.5 KB
2025-07-08 20:00
Major Shareholding Notification
FR Transparency BR.pdf
French 294.4 KB
2025-07-08 20:00
Major Shareholding Notification
NL Transparency BR.pdf
Dutch 299.5 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-05 Caeymaex Emmanuel Executive member Sell 4,000 646,200.00 EUR
2024-09-05 Caeymaex Emmanuel Executive member Buy 4,000 281,040.00 EUR
2024-08-01 Caeymaex Emmanuel Executive member Sell 4,300 669,075.70 EUR
2024-08-01 Caeymaex Emmanuel Executive member Buy 4,300 289,132.00 EUR
2024-07-31 Tellier Jean-Christophe Executive member Sell 26,800 4,139,822.80 EUR
2024-07-31 Tellier Jean-Christophe Executive member Buy 26,800 1,804,980.00 EUR
2024-07-31 Caeymaex Emmanuel Executive member Sell 4,304 666,151.60 EUR
2024-07-31 Caeymaex Emmanuel Executive member Buy 4,304 289,400.96 EUR
2024-07-31 Greene Nefertiti Board Buy 150 23,167.50 EUR
2024-07-08 Patel Dhavalkumar Executive member Buy 169 19,832.15 EUR

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
AnGes, Inc. Logo AnGes, Inc. Japan 4563